Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
6,763 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00098969 | UMCC 2003-064 Resveratrol in Preventing Cancer in Healthy Participants(IRB 2004-535) | completed | Phase 1 | 40 | National Cancer Institute (NCI)NIH | 2 | Dec 17, 2012 | clinicaltrials |
| NCT00824785 | REAL3 Trial of Efficacy of EOX With/Without Panitumumab in Previously Untreated Adv OG Cancer(REAL3) | terminated | Phase 3 | 574 | Royal Marsden NHS Foundation TrustOTHER | 1 | Dec 11, 2012 |
| clinicaltrials |
| NCT01308762 | A Clinical Study, to Evaluate the Safety and Tolerability of Intradermal IMM-101 in Adult Melanoma Cancer Patients | completed | Phase 1 | 19 | Immodulon Therapeutics LtdINDUSTRY | 1 | Dec 6, 2012 | clinicaltrials |
| NCT00744510 | Reflexology's Effect on Polycystic Ovary Syndrome (PCOS)(REPOS) | unknown | Phase 3 | 140 | University of NottinghamOTHER | 1 | Dec 4, 2012 | clinicaltrials |
| NCT00746148 | Reflexology's Effect on Polycystic Ovary Syndrome: A Pilot Study(REPOS) | unknown | Phase 3 | 140 | University of NottinghamOTHER | 1 | Dec 4, 2012 | clinicaltrials |
| NCT01320319 | Effect of EPA on Aerobic Performance, Muscle, and Quality of Life in Colorectal Cancer Surgery Patients(EPA-colo) | unknown | Phase 2 / Phase 3 | 70 | University of NottinghamOTHER | 1 | Dec 4, 2012 | clinicaltrials |
| NCT01243398 | Gefitinib in Treating Patients With Esophageal Cancer That is Progressing After Chemotherapy | completed | Phase 3 | 450 | University of OxfordOTHER | 1 | Nov 29, 2012 | clinicaltrials |
| NCT00306891 | Effect of Food Upon Pharmacokinetics of Single Oral Dose of Cediranib (AZD2171, Recentin™) | completed | Phase 2 | 60 | AstraZenecaINDUSTRY | 1 | Nov 1, 2012 | clinicaltrials |
| NCT01716780 | Pain: Screen and Treat | unknown | Phase 3 | 156 | Royal Marsden NHS Foundation TrustOTHER | 1 | Oct 30, 2012 | clinicaltrials |
| NCT01045603 | Instanyl® Non-Interventional Study(INIS) | completed | — | 309 | TakedaINDUSTRY | 7 | Oct 29, 2012 | clinicaltrials |
| NCT01191931 | Prostate HistoScanning for the Non-invasive Detection and Staging of Prostate Cancer and Characterization of Prostate Tissues (PHS-02)(PHS-02) | completed | — | 52 | Advanced Medical Diagnostics s.a.INDUSTRY | 5 | Oct 29, 2012 | clinicaltrials |
| NCT00065468 | Study Evaluating Interferon And CCI-779 In Advanced Renal Cell Carcinoma(ARCC) | completed | Phase 3 | 626 | PfizerINDUSTRY | 25 | Oct 25, 2012 | clinicaltrials |
| NCT00278889 | Second Line ColoRectal Cancer Therapy in Combination With Combination of FOL- Folinic Acid(Leucovorin), F - Fluorouracil and OX - Oxaliplatin (FOLFOX)(HORIZON I) | completed | Phase 2 | 215 | AstraZenecaINDUSTRY | 9 | Oct 24, 2012 | clinicaltrials |
| NCT00742495 | Pharmacokinetic Study of Forodesine in Children With Relapsed or Refractory T-cell or B-cell Precursor Acute Lymphoblastic Leukaemia or T-cell Non- Hodgkin's Lymphoma.(BCX1777-108) | terminated | Phase 1 / Phase 2 | 2 | Mundipharma Research LimitedINDUSTRY | 6 | Oct 24, 2012 | clinicaltrials |
| NCT01678430 | A Trial Looking at Ofatumumab for People With Chronic Lymphocytic Leukaemia Who Cannot Have More Intensive Treatment(RIAltO) | unknown | Phase 3 | 670 | University of LiverpoolOTHER | 1 | Oct 15, 2012 | clinicaltrials |
| NCT00833248 | Neoadjuvant Study Investigating Degarelix in Patients Suffering From Prostate Cancer | completed | Phase 3 | 246 | Ferring PharmaceuticalsINDUSTRY | 7 | Oct 4, 2012 | clinicaltrials |
| NCT01698359 | Evaluation of Ultrasound Probe for Use in Bladder Radiotherapy | unknown | — | 5 | University Hospital Birmingham NHS Foundation TrustOTHER | 1 | Oct 3, 2012 | clinicaltrials |
| NCT00842829 | Study of Breakthrough Cancer Pain: Assessment of Fentanyl Buccal Tablets Titration and Treatment in Opioid-Tolerant Patients | terminated | Phase 4 | 330 | CephalonINDUSTRY | 7 | Oct 1, 2012 | clinicaltrials |
| NCT00561470 | Aflibercept Versus Placebo in Combination With Irinotecan and 5-FU in the Treatment of Patients With Metastatic Colorectal Cancer After Failure of an Oxaliplatin Based Regimen(VELOUR) | completed | Phase 3 | 1,226 | SanofiINDUSTRY | 28 | Sep 28, 2012 | clinicaltrials |
| NCT00595777 | Edinburgh Pain Assessment Tool (EPAT©) Study(EPAT©) | completed | N/A | 1,928 | University of EdinburghOTHER | 1 | Sep 26, 2012 | clinicaltrials |
| NCT01048320 | Gemcitabine and Oxaliplatin (Gem-Ox) Plus Glivec in Gemcitabine-refractory Pancreatic Cancer(RPGOG1) | completed | Phase 1 | 36 | Royal Marsden NHS Foundation TrustOTHER | 1 | Sep 25, 2012 | clinicaltrials |
| NCT00002459 | Radiation Therapy or No Further Treatment Following Surgery in Treating Patients With Cancer of the Uterus | completed | Phase 3 | 224 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 10 | Sep 24, 2012 | clinicaltrials |
| NCT00002503 | Strontium Compared With Radiation Therapy in Treating Patients With Hormone-Refractory Prostate Cancer With Painful Bone Metastases | completed | Phase 3 | 204 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Sep 24, 2012 | clinicaltrials |
| NCT00002539 | Combination Chemotherapy and Surgery With or Without G-CSF in Treating Patients With Osteosarcoma | completed | Phase 3 | 214 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 8 | Sep 24, 2012 | clinicaltrials |
| NCT00003731 | Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors | completed | Phase 2 | 39 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Sep 24, 2012 | clinicaltrials |
| NCT00003805 | Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count | completed | Phase 3 | 859 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 13 | Sep 24, 2012 | clinicaltrials |
| NCT00003916 | Standard Radiation Therapy With or Without Stereotactic Radiation Therapy in Treating Patients With Glioma | completed | Phase 3 | 25 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 7 | Sep 24, 2012 | clinicaltrials |
| NCT00003941 | Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Men With Previously Untreated Germ Cell Cancer | completed | Phase 3 | 222 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 12 | Sep 24, 2012 | clinicaltrials |
| NCT00004884 | Docetaxel and Gemcitabine Compared With Docetaxel and Cisplatin in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer | completed | Phase 2 | 96 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 8 | Sep 24, 2012 | clinicaltrials |
| NCT00006230 | Nitrocamptothecin in Treating Patients With Advanced Ovarian Cancer | completed | Phase 2 | 51 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 7 | Sep 24, 2012 | clinicaltrials |
| NCT00006357 | STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma | completed | Phase 1 / Phase 2 | 91 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 5 | Sep 24, 2012 | clinicaltrials |
| NCT00014313 | Chemotherapy in Treating Patients With Metastatic Ewing's Sarcoma or Primitive Neuroectodermal Tumor | terminated | Phase 2 | 3 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Sep 24, 2012 | clinicaltrials |
| NCT00014599 | Paclitaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the Vulva | completed | Phase 2 | 31 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 6 | Sep 24, 2012 | clinicaltrials |
| NCT00016211 | Radiation Therapy to Prevent Brain Metastases in Patients With Previously Treated Extensive-Stage Small Cell Lung Cancer | completed | Phase 3 | 287 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 12 | Sep 24, 2012 | clinicaltrials |
| NCT00017277 | Radiation Therapy With or Without Epoetin Alfa in Treating Patients With Head and Neck Cancer | terminated | Phase 3 | 47 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 10 | Sep 24, 2012 | clinicaltrials |
| NCT00020839 | Temozolomide With or Without Radiation Therapy to the Brain in Treating Patients With Stage IV Melanoma That Is Metastatic to the Brain | terminated | Phase 3 | 23 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 11 | Sep 24, 2012 | clinicaltrials |
| NCT00022620 | Paclitaxel in Treating Patients With Refractory or Recurrent Endometrial Cancer | completed | Phase 2 | — | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 6 | Sep 24, 2012 | clinicaltrials |
| NCT00023842 | BCG With or Without Mitomycin in Treating Patients With Bladder Cancer | completed | Phase 2 | 97 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 6 | Sep 24, 2012 | clinicaltrials |
| NCT00025298 | Chemotherapy Plus Radiation Therapy With or Without Amifostine in Treating Patients With Locally Advanced Cancer of the Nasopharynx | terminated | Phase 2 | 5 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 6 | Sep 24, 2012 | clinicaltrials |
| NCT00039351 | Combination Chemotherapy in Treating Older Patients With Non-Hodgkin's Lymphoma | completed | Phase 2 | 32 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 7 | Sep 24, 2012 | clinicaltrials |
| NCT00043004 | Chemotherapy and Bevacizumab With or Without Radiofrequency Ablation in Treating Unresectable Liver Metastases in Patients With Colorectal Cancer | terminated | Phase 2 | 119 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 10 | Sep 24, 2012 | clinicaltrials |
| NCT00052312 | Doxorubicin and Cisplatin With or Without Paclitaxel in Treating Patients With Locally Advanced, Metastatic, and/or Relapsed Endometrial Cancer | completed | Phase 2 | 141 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 8 | Sep 24, 2012 | clinicaltrials |
| NCT00052754 | Gefitinib in Treating Patients With Locally Advanced or Metastatic Synovial Sarcoma | completed | Phase 2 | 48 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 4 | Sep 24, 2012 | clinicaltrials |
| NCT00053807 | Interleukin-2, Interferon Alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney Cancer | completed | Phase 3 | 96 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 8 | Sep 24, 2012 | clinicaltrials |
| NCT00066391 | Irinotecan and Cisplatin in Treating Patients With Locally Advanced or Metastatic Penile Cancer | completed | Phase 2 | — | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 6 | Sep 24, 2012 | clinicaltrials |
| NCT00085228 | Docetaxel With or Without Oblimersen in Treating Patients With Hormone-Refractory Adenocarcinoma (Cancer) of the Prostate | completed | Phase 2 | 116 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 11 | Sep 24, 2012 | clinicaltrials |
| NCT00085475 | Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans or Giant Cell Fibroblastoma | completed | Phase 2 | 17 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 4 | Sep 24, 2012 | clinicaltrials |
| NCT00110123 | Intravenous or Hepatic Arterial Infusion of Fotemustine in Treating Patients With Unresectable Liver Metastases From Eye Melanoma | terminated | Phase 3 | 171 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 4 | Sep 24, 2012 | clinicaltrials |
| NCT00677105 | A Safety and Dose-finding Study of JNJ-26481585 for Patients With Advanced Solid Malignancies and Lymphoma. | completed | Phase 1 | 92 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.INDUSTRY | 1 | Sep 17, 2012 | clinicaltrials |
| NCT00617669 | A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) and Docetaxel in Metastatic Hormone Resistant Prostate Cancer(ENTHUSE M1C) | completed | Phase 3 | 1,494 | AstraZenecaINDUSTRY | 26 | Sep 10, 2012 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials